Literature DB >> 14107074

USE OF ETHOGLUCID IN TREATMENT OF ADVANCED MALIGNANT DISEASE.

M R BOND, S D CLARKE, F E NEAL.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; ETHOGLUCID; INFUSIONS, PARENTERAL; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; INTESTINAL NEOPLASMS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NECK NEOPLASMS; OVARIAN NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS

Mesh：

Substances：

Year:  1964        PMID： 14107074      PMCID： PMC1814150          DOI： 10.1136/bmj.1.5388.951

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Treatment of advanced cancer by extracorporeal perfusion and continuous intra-arterial infusion.

Authors:  G WESTBURY
Journal:  Proc R Soc Med       Date:  1962-08

2.  The effect of anticancer agents on nervous tissue.

Authors:  M S MAHALEY; B WOODHALL
Journal:  Cancer Chemother Rep       Date:  1962-02

3.  Effects of intra-arterial administration of nitrogen mustard.

Authors:  J R BARBERIO; C T KLOPP; W W AYRES; H A GROSS
Journal:  Cancer       Date:  1951-11       Impact factor: 6.860

4.  Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report.

Authors:  C T KLOPP; T C ALFORD; J BATEMAN; G N BERRY; T WINSHIP
Journal:  Ann Surg       Date:  1950-10       Impact factor: 12.969
  4 in total
  4 in total

1.  ETHOGLUCIDE IN TREATMENT OF INOPERABLE LUNG CANCER.

Authors:  A W LEES
Journal:  Br Med J       Date:  1965-01-23

2.  EXPERIMENTAL AND CLINICAL OBSERVATIONS CONCERNING THE NEUROTOXICITY OF ETHOGLUCID.

Authors:  M R BOND; L WOLMAN
Journal:  Br Med J       Date:  1965-05-01

3.  Drug-induced peripheral neuropathies.

Authors:  Z Argov; F L Mastaglia
Journal:  Br Med J       Date:  1979-03-10

Review 4.  Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment.

Authors:  Tianyi Liu; Min Hou; Manyu Li; Cheng Qiu; Lin Cheng; Tianyu Zhu; Jinfeng Qu; Lanyu Li
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.